Madelung's Disease
Benign symmetric lipomatosis is rare enough that many patients have never met a physician who has seen more than a handful of cases. Our flagship condition.
What we mean when we say Madelung's Disease.
Madelung's Disease — also known as benign symmetric lipomatosis or Launois-Bensaude syndrome — is a rare disorder characterized by the symmetric accumulation of non-encapsulated adipose tissue, most commonly in the neck, shoulders, and upper back.
Despite being classified as benign, it can produce substantial functional and cosmetic impact, and is associated in the literature with metabolic, hepatic, and neurologic findings that often go unexplored in routine care.
Because the condition is uncommon, most clinicians encounter it rarely, and case-specific expertise is difficult to assemble across a single medical team.
The pattern we see in Madelung's Disease cases.
- 01The condition is rare, and even specialists who recognize it often haven't seen a representative range of presentations. Patients are regularly told their situation is cosmetic, when it is not.
- 02Associated findings — peripheral neuropathy, autonomic dysfunction, metabolic abnormalities, mitochondrial signals in some subtypes — tend to be noted by one specialist and forgotten by the next, rather than tracked as a coherent picture.
- 03Surgical decisions (lipectomy, liposuction, staging) vary widely by center. Without a synthesized record, it's difficult for a patient to evaluate recommendations from different surgical teams.
- 04The literature is scattered across dermatology, endocrinology, plastic surgery, neurology, and hepatology journals — and genuine subtype distinctions exist but are not always applied in clinical settings.
The Ternary Signal Library for Madelung's Disease.
Our Signal Library codifies the specific patterns that matter in Madelung's Disease — labs, genetic variants, imaging findings, symptom clusters, and comorbidity combinations. Your case is mapped against these signals in Stage 4 of the workflow; each activated signal is weighted and prioritized for your presentation.
- —Triglycerides, LDL-C, HDL, ApoB — dyslipidemia patterns
- —ALT, AST, GGT, ALP — hepatic involvement
- —Ferritin, transferrin saturation, iron — iron overload axis
- —HbA1c, fasting insulin — metabolic syndrome indicators
- —Testosterone (total, free), SHBG — common Madelung-adjacent findings
- —Vitamin D, B12, B6 (PLP) — correctable deficiencies
- —HFE — C282Y and H63D — iron overload risk
- —APOE — metabolic context
- —ADH1B / ALDH2 — alcohol-metabolism variants
- —Mitochondrial variants (limited in consumer genotyping)
- —Lipid-metabolism genes relevant to subtype
- —Contrast-enhanced MRI of the neck — depth of infiltration
- —Distribution pattern — Type I / II / III classification
- —Deep vs. superficial cervical extension
- —Airway compromise assessment
- —Sleep study findings if OSA is suspected
- —Chronic alcohol exposure timeline
- —Obstructive sleep apnea and neck-mass airway effects
- —Fatty liver / hepatic fibrosis status
- —Peripheral neuropathy, autonomic dysfunction
- —Prior surgical history and recurrence pattern
The Ternary Health approach to Madelung's Disease.
Review the full history — imaging, distribution, prior surgeries, associated findings — and classify the presentation against published subtypes where the data supports it.
Integrate labs, hepatic workup, metabolic markers, and any autonomic or neurologic findings into a single view, rather than treating them as separate complaints.
If genomic data is available, look for variants associated with mitochondrial function and lipid metabolism that have been linked to Madelung-type presentations in the literature.
Map the surgical and medical options — evidence base, typical outcomes, trade-offs between aggressive and conservative approaches — so you can make informed decisions with your surgical team.
How a Madelung's Disease case moves through our workflow.
Our nine-stage workflow is the same for every engagement. What changes per condition is the content at each stage — the records we pull, the signals we apply, the specialists we map, the pathways we evaluate. Below, how your case specifically would move through each stage.
What you receive.
- —A written case synthesis covering distribution, subtype, and associated findings
- —Integration of imaging, labs, and metabolic workup into a single view
- —Optional genome-informed analysis highlighting relevant variants
- —A surgical / non-surgical decision framework grounded in the literature
- —Specialist identification for consultations you may want to consider
- —A written action plan and follow-up support as you implement it
What prospective Madelung's Disease clients ask most.
Ready for a case review?
Applications are reviewed within three business days.